Cargando…

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception

PURPOSE: Herein, we report the frequency and distribution of germline pathogenic variants (PVs) among females with breast cancer (BC) and at least one other non-BC who underwent multi-gene panel testing (MGPT). Among females with PVs diagnosed first with BC or ovarian cancer (OC), we sought to enume...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bychkovsky, Brittany L., Lo, Min-Tzu, Yussuf, Amal, Horton, Carrie, Hemyari, Parichehr, LaDuca, Holly, Garber, Judy E., Scheib, Rochelle, Rana, Huma Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224857/ https://www.ncbi.nlm.nih.gov/pubmed/36856935 http://dx.doi.org/10.1007/s10549-023-06870-x

Ejemplares similares

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
por: Pritzlaff, Mary, et al.
Publicado: (2016)

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen
por: Bychkovsky, Brittany, et al.
Publicado: (2022)

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center
por: Elliott, Elizabeth, et al.
Publicado: (2020)

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition
por: Kamihara, Junne, et al.
Publicado: (2022)

Universal Multi Gene Panel Testing For Individuals With Pheochromocytomas And Paragangliomas
por: Horton, Carolyn, et al.
Publicado: (2021)

Breast cancer prognosis in relation to family history of breast and ovarian cancer
por: Thalib, L, et al.
Publicado: (2004)

Variations in breast cancer surgical treatment and timing: determinants and disparities
por: Dankwa-Mullan, Irene, et al.
Publicado: (2021)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
por: Sund, Maria, et al.
Publicado: (2023)

The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
por: Nout, R. A., et al.
Publicado: (2007)

Are rare cancer survivors at elevated risk of subsequent new cancers?
por: Finkelstein, Dianne M., et al.
Publicado: (2019)

Cancer risk after radiotherapy for breast cancer
por: Levi, F, et al.
Publicado: (2006)

Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors
por: Freedman, Rachel A., et al.
Publicado: (2022)

Heritable breast cancer in twins
por: Mack, T M, et al.
Publicado: (2002)

Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer
por: Abubakar, Mustapha, et al.
Publicado: (2021)

A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients
por: Bennett, K E, et al.
Publicado: (2002)

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer
por: Kwast, A B G, et al.
Publicado: (2012)

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
por: Work, M E, et al.
Publicado: (2014)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield
por: Horton, Carolyn, et al.
Publicado: (2022)

Birth outcome in women with breast cancer
por: Langagergaard, V, et al.
Publicado: (2006)

Wait times for breast cancer care
por: Saint-Jacques, N, et al.
Publicado: (2007)

Dietary patterns and risk of breast cancer
por: Baglietto, L, et al.
Publicado: (2011)

Birth intervals and breast cancer risk
por: Kauppila, A, et al.
Publicado: (2009)

Sclerosing adenosis and risk of breast cancer
por: Visscher, Daniel W., et al.
Publicado: (2014)

Prognostic models in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2016)

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
por: Berrington de Gonzalez, A, et al.
Publicado: (2010)

Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors
por: Miller, Matthew M., et al.
Publicado: (2021)

Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening
por: Román, M, et al.
Publicado: (2017)

Breast self-examination and death from breast cancer: a meta-analysis
por: Hackshaw, A K, et al.
Publicado: (2003)

Breast cancer risk feedback to women in the UK NHS breast screening population
por: Evans, D Gareth R, et al.
Publicado: (2016)

The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
por: Cullinane, C., et al.
Publicado: (2022)

On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk
por: Soerjomataram, Isabelle, et al.
Publicado: (2007)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
por: Kriege, M, et al.
Publicado: (2014)

Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark
por: Collin, Lindsay J, et al.
Publicado: (2018)

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis
por: Jeon, Ye Won, et al.
Publicado: (2019)

Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
por: Ren, Megan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2c5474b3ecqs79d9uoii8k7i4e